We are pleased to announce that PrLONSURF® (trifluridine and tipiracil) is now available in Canada as of January 23, 2018.
Canadian regulations limit the scope of information we are permitted to give on prescription drugs via the internet or other means.
To learn more about LONSURF, please visit the links below:
PrLONSURF® Product Monograph
PrLONSURF® Consumer Information
We are pleased to announce that PrINQOVI® (decitabine and cedazuridine tablets) is now available in Canada as of July 7, 2020.
Canadian regulations limit the scope of information we are permitted to give on prescription drugs via the internet or other means.
To learn more about INQOVI, please visit the links below
PrINQOVI® Product Monograph
PrINQOVI® Consumer Information
Please consult a qualified health professional for more detailed information.
Please contact Taiho Medical Information at Medicalinformation@taihopharma.ca or 1-844-MI-TAIHO (844-648-2446) with any comments or inquiries.
Please refer to the Health Canada Website for Health Canada Advisories and Warnings.https://www.taihopharma.ca/documents/35/LONSURF_Product_Monograph.pdf
You are now leaving Taiho Pharma Canada’s website.
Taiho Pharma Canada assumes no responsibility for, nor does it endorse any aspect of your use of any third party sites.
Thank you for visiting our site.
Continue